Pharmaceuticals & Medical Research Sector Insider Trading Activity

Suivez les achats et ventes d’initiés sur les actions de Healthcare. Découvrez quels dirigeants achètent, l’activité nette des initiés et le pourcentage du flottant échangé parmi 2,058 sociétés.
Les informations fournies dans ce classement sont à titre informatif uniquement et ne constituent pas un conseil financier. Nous ne recommandons aucun investissement spécifique basé sur ces critères.
Entreprises
Données
Abonnez-vous pour accéder à l'ensemble des données
Entreprise Branche d'activité Cap. boursière (USDm) # acheteurs nets Valeur nette ($) % du flottant acheté % d'actions détenues par les initiés
Pharmaceuticals Mega (1.1tn) 0 Aucune activité — 0–15%
Pharmaceuticals Mega (614.4bn) -1–5 -$10M–$100M -0–15% 0–15%
US Abbvie Inc (ABBV)
Pharmaceuticals Mega (453.9bn) 0 Aucune activité — 0–15%
Pharmaceuticals Mega (313.6bn) 0 Aucune activité — —
Pharmaceuticals Mega (307.2bn) -1–5 -$10M–$100M -0–15% 0–15%
CH Novartis AG (NOVN)
Pharmaceuticals Mega (298.2bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals Mega (247.3bn) -1–5 -$1M–$10M -0–15% 0–15%
US Amgen Inc (AMGN)
Pharmaceuticals Mega (222.3bn) -1–5 -$1M–$10M -0–15% 0–15%
DK Novo Nordisk A/S (NOVO-B)
Pharmaceuticals Mega (201.4bn) 0 Aucune activité — 0–15%
Biotechnology & Medical Research Large (161.7bn) 0 Aucune activité — 0–15%
US Pfizer Inc (PFE)
Pharmaceuticals Large (144.8bn) 1–5 $1M–$10M 0–15% 0–15%
Pharmaceuticals Large (132.4bn) 0 Aucune activité — 0–15%
Biotechnology & Medical Research Large (119.9bn) 0 Aucune activité — 0–15%
GB GSK plc (GSK)
Pharmaceuticals Large (107.4bn) 11–20 -$100K–$1M -0–15% 0–15%
FR Sanofi SA (SAN)
Pharmaceuticals Large (102.5bn) 0 Aucune activité — 0–15%
AU CSL Ltd (CSL)
Pharmaceuticals Large (90.6bn) 0 Aucune activité — 0–15%
Biotechnology & Medical Research Large (80.8bn) 0 Aucune activité — 0–15%
US Celgene Corp (CELG)
Pharmaceuticals Large (77.0bn) 0 Aucune activité — —
Biotechnology & Medical Research Large (65.3bn) 0 Aucune activité — 0–15%
US Allergan plc (AGN)
Pharmaceuticals Large (63.7bn) 0 Aucune activité — 0–15%
DE Bayer AG (BAYN)
Pharmaceuticals Large (55.1bn) 1–5 $1M–$10M 0–15% —
NL argenx SE (ARGX)
Biotechnology & Medical Research Large (54.7bn) -1–5 -$1M–$10M -0–15% 0–15%
BE Ucb SA (UCB)
Pharmaceuticals Large (49.4bn) 1–5 $100K–$1M 0–15% 15–50%
Biotechnology & Medical Research Large (46.8bn) -1–5 -< $100K -0–15% 0–15%
Biotechnology & Medical Research Large (44.0bn) 0 Aucune activité — 0–15%
US Seagen Inc (SGEN)
Biotechnology & Medical Research Large (43.2bn) 0 Aucune activité — 0–15%
GB Haleon PLC (HLN)
Pharmaceuticals Large (41.0bn) 1–5 $100K–$1M 0–15% 0–15%
Biotechnology & Medical Research Large (40.0bn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals Large (38.8bn) -1–5 -$100K–$1M -0–15% 0–15%
Biotechnology & Medical Research Large (38.3bn) 0 Aucune activité — 0–15%
Pharmaceuticals Large (33.8bn) 0 Aucune activité — 0–15%
Pharmaceuticals Large (32.0bn) 0 Aucune activité — 50%+
US Zoetis Inc (ZTS)
Pharmaceuticals Large (31.9bn) 1–5 $100K–$1M 0–15% 0–15%
US Biogen Inc (BIIB)
Pharmaceuticals Large (30.0bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals Large (26.6bn) 0 Aucune activité — 0–15%
Biotechnology & Medical Research Large (26.1bn) 0 Aucune activité — 0–15%
Biotechnology & Medical Research Large (25.2bn) -6–10 -$100M+ -0–15% 15–50%
US Incyte Corp (INCY)
Biotechnology & Medical Research Large (23.7bn) -6–10 -$10M–$100M -0–15% 0–15%
DE Biontech SE (BNTX)
Biotechnology & Medical Research Large (23.3bn) 0 Aucune activité — 50%+
US Moderna Inc (MRNA)
Biotechnology & Medical Research Large (22.8bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals Large (22.5bn) 1–5 -$1M–$10M -0–15% 50%+
US Insmed Inc (INSM)
Biotechnology & Medical Research Large (21.5bn) -1–5 -$1M–$10M -0–15% 0–15%
Biotechnology & Medical Research Large (21.3bn) -11–20 -$10M–$100M -0–15% 0–15%
US Viatris Inc (VTRS)
Pharmaceuticals Large (20.5bn) 0 Aucune activité — 0–15%
Biotechnology & Medical Research Large (20.3bn) 0 Aucune activité — 0–15%
Biotechnology & Medical Research Large (20.0bn) 0 Aucune activité — 0–15%
Pharmaceuticals Large (19.4bn) 0 Aucune activité — 50%+
Biotechnology & Medical Research Large (18.2bn) 0 Aucune activité — 0–15%
Biotechnology & Medical Research Large (17.7bn) 1–5 $100K–$1M 0–15% 0–15%
Pharmaceuticals Large (16.6bn) -6–10 -$10M–$100M -0–15% 0–15%
DK Genmab A/S (GMAB)
Biotechnology & Medical Research Large (16.5bn) 0 Aucune activité — —
Biotechnology & Medical Research Large (16.3bn) -1–5 -$10M–$100M -0–15% 15–50%
FR Ipsen SA (IPN)
Pharmaceuticals Large (16.0bn) 0 Aucune activité — 50%+
IN Cipla Ltd (CIPLA)
Pharmaceuticals Large (15.9bn) 0 Aucune activité — 15–50%
Pharmaceuticals Large (15.9bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals Large (15.3bn) 0 Aucune activité — 0–15%
Biotechnology & Medical Research Large (14.0bn) 0 Aucune activité — 0–15%
Pharmaceuticals Large (13.5bn) 0 Aucune activité — 50%+
US Exelixis Inc (EXEL)
Biotechnology & Medical Research Large (13.4bn) -1–5 -$1M–$10M -0–15% 0–15%
FI Orion Oyj (ORNBV)
Pharmaceuticals Large (13.0bn) 0 Aucune activité — 0–15%
Pharmaceuticals Large (12.9bn) 0 Aucune activité — 50%+
Biotechnology & Medical Research Large (12.8bn) -1–5 -$1M–$10M -0–15% 0–15%
Biotechnology & Medical Research Large (12.8bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals Large (12.7bn) 0 Aucune activité — 15–50%
IE ICON PLC (ICLR)
Biotechnology & Medical Research Large (12.7bn) 0 Aucune activité — 0–15%
Biotechnology & Medical Research Large (12.6bn) 0 Aucune activité — 0–15%
Pharmaceuticals Large (12.4bn) 0 Aucune activité — 0–15%
FR Abivax SA (ABVX)
Biotechnology & Medical Research Large (12.3bn) 0 Aucune activité — 0–15%
Pharmaceuticals Large (12.1bn) 0 Aucune activité — 50%+
US MyoKardia Inc (MYOK)
Biotechnology & Medical Research Large (12.0bn) 0 Aucune activité — 0–15%
US Catalent Inc (CTLT)
Pharmaceuticals Large (11.5bn) 0 Aucune activité — 0–15%
Biotechnology & Medical Research Large (11.2bn) 0 Aucune activité — 0–15%
Pharmaceuticals Large (11.0bn) 1–5 $100K–$1M 0–15% 0–15%
Biotechnology & Medical Research Large (11.0bn) -1–5 -$10M–$100M -0–15% 0–15%
Biotechnology & Medical Research Large (10.9bn) 0 Aucune activité — 0–15%
Biotechnology & Medical Research Large (10.9bn) 0 Aucune activité — 15–50%
Biotechnology & Medical Research Large (10.6bn) -6–10 -$10M–$100M -0–15% 0–15%
Biotechnology & Medical Research Large (10.5bn) 0 Aucune activité — 0–15%
Biotechnology & Medical Research Large (10.4bn) 1–5 $100M+ 0–15% 50%+
Biotechnology & Medical Research Large (10.2bn) 0 Aucune activité — 0–15%
Biotechnology & Medical Research Large (10.2bn) 0 Aucune activité — 0–15%
Pharmaceuticals Mid (10.0bn) -1–5 -$1M–$10M -0–15% 0–15%
US Nuvalent Inc (NUVL)
Biotechnology & Medical Research Mid (9.8bn) 0 Aucune activité — 0–15%
Biotechnology & Medical Research Mid (9.6bn) 0 Aucune activité — 15–50%
Biotechnology & Medical Research Mid (9.4bn) -1–5 -$1M–$10M -0–15% 0–15%
Biotechnology & Medical Research Mid (9.1bn) -1–5 -$1M–$10M -0–15% 0–15%
Biotechnology & Medical Research Mid (9.1bn) -1–5 -$100M+ -0–15% 0–15%
Biotechnology & Medical Research Mid (9.1bn) 0 Aucune activité — 0–15%
Biotechnology & Medical Research Mid (8.9bn) 0 Aucune activité — 0–15%
Biotechnology & Medical Research Mid (8.9bn) 1–5 $1M–$10M 0–15% 0–15%
US ImmunoGen Inc (IMGN)
Biotechnology & Medical Research Mid (8.7bn) 0 Aucune activité — 0–15%
US Mylan NV (MYL)
Pharmaceuticals Mid (8.6bn) 0 Aucune activité — 0–15%
Biotechnology & Medical Research Mid (8.4bn) 0 Aucune activité — 0–15%
IE Alkermes Plc (ALKS)
Biotechnology & Medical Research Mid (8.2bn) -1–5 -$1M–$10M -0–15% 0–15%
Biotechnology & Medical Research Mid (8.2bn) 0 Aucune activité — 50%+
Biotechnology & Medical Research Mid (8.1bn) -6–10 -$10M–$100M -0–15% 50%+
US Liquidia Corp (LQDA)
Biotechnology & Medical Research Mid (8.0bn) -1–5 -$100M+ -0–15% 0–15%
Biotechnology & Medical Research Mid (7.9bn) -1–5 -$100K–$1M -0–15% 0–15%
Biotechnology & Medical Research Mid (7.9bn) 0 Aucune activité — 0–15%
US Vaxcyte Inc (PCVX)
Biotechnology & Medical Research Mid (7.8bn) 0 Aucune activité — 0–15%